Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8609523 | Anaesthesia Critical Care & Pain Medicine | 2017 | 7 Pages |
Abstract
The budget impact analysis shows that even though atropine PFS is more expensive than atropine CMP, its use would lead to significant cost savings. Savings would mainly be due to fewer medication errors and their associated consequences and the absence of wastage when atropine syringes are prepared in advance.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Dan Benhamou, Vincent Piriou, Cyrille De Vaumas, Pierre Albaladejo, Jean-Marc Malinovsky, Marianne Doz, Antoine Lafuma, Hervé Bouaziz,